News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
89,223 Results
Type
Article (11102)
Company Profile (6)
Press Release (78115)
Multimedia
Podcasts (70)
Webinars (3)
Section
Business (22656)
Career Advice (577)
Deals (4162)
Drug Delivery (45)
Drug Development (14655)
Employer Resources (46)
FDA (2871)
Job Trends (2642)
News (43725)
Policy (4228)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
Academia (591)
Accelerated approval (12)
Adcomms (5)
Allergies (28)
Alliances (4329)
ALS (93)
Alzheimer's disease (801)
Antibody-drug conjugate (ADC) (48)
Approvals (2901)
Artificial intelligence (90)
Autoimmune disease (47)
Automation (6)
Bankruptcy (46)
Best Places to Work (1955)
BIOSECURE Act (8)
Biosimilars (32)
Biotechnology (4)
Bladder cancer (19)
Brain cancer (14)
Breast cancer (96)
Cancer (759)
Cardiovascular disease (75)
Career advice (503)
Career pathing (14)
CAR-T (72)
CDC (15)
Cell therapy (180)
Cervical cancer (2)
Clinical research (12564)
Collaboration (225)
Company closure (1)
Compensation (54)
Complete response letters (13)
COVID-19 (607)
CRISPR (22)
C-suite (71)
Cystic fibrosis (19)
Data (1420)
Denatured (3)
Depression (38)
Diabetes (157)
Diagnostics (732)
Digital health (11)
Diversity (2)
Diversity, equity & inclusion (11)
Drug discovery (51)
Drug pricing (69)
Drug shortages (7)
Duchenne muscular dystrophy (83)
Earnings (13530)
Editorial (32)
Employer branding (3)
Employer resources (39)
Events (12047)
Executive appointments (90)
FDA (3499)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (5)
Frontotemporal dementia (8)
Funding (206)
Gene editing (36)
Generative AI (6)
Gene therapy (158)
GLP-1 (354)
Government (899)
Grass and pollen (3)
Guidances (112)
Healthcare (2548)
HIV (13)
Huntington's disease (34)
IgA nephropathy (34)
Immunology and inflammation (59)
Immuno-oncology (11)
Indications (17)
Infectious disease (649)
Inflammatory bowel disease (20)
Inflation Reduction Act (4)
Influenza (14)
Intellectual property (30)
Interviews (121)
IPO (2005)
IRA (21)
Job creations (738)
Job search strategy (407)
JPM (30)
Kidney cancer (4)
Labor market (41)
Layoffs (253)
Leadership (8)
Legal (742)
Liver cancer (11)
Longevity (5)
Lung cancer (95)
Lymphoma (130)
Machine learning (8)
Management (16)
Manufacturing (110)
MASH (46)
Medical device (1807)
Medtech (1813)
Mergers & acquisitions (2312)
Metabolic disorders (409)
Multiple sclerosis (70)
NASH (11)
Neurodegenerative disease (162)
Neuropsychiatric disorders (23)
Neuroscience (1285)
Neurotech (1)
NextGen: Class of 2026 (862)
Non-profit (785)
Now hiring (11)
Obesity (208)
Opinion (128)
Ovarian cancer (22)
Pain (51)
Pancreatic cancer (33)
Parkinson's disease (127)
Partnered (8)
Patents (68)
Patient recruitment (68)
Peanut (15)
People (4522)
Pharmaceutical (1)
Pharmacy benefit managers (5)
Phase 1 (3282)
Phase 2 (5581)
Phase 3 (4884)
Pipeline (1175)
Policy (100)
Postmarket research (519)
Preclinical (1138)
Press Release (4)
Prostate cancer (21)
Psychedelics (11)
Radiopharmaceuticals (30)
Rare diseases (214)
Real estate (472)
Recruiting (20)
Regulatory (3502)
Reports (16)
Research institute (445)
Resumes & cover letters (65)
Rett syndrome (13)
RNA editing (3)
RSV (17)
Schizophrenia (46)
Series A (29)
Series B (16)
Sickle cell disease (24)
Special edition (12)
Spinal muscular atrophy (28)
Sponsored (10)
Startups (408)
Stomach cancer (4)
Supply chain (15)
Tariffs (37)
The Weekly (65)
Vaccines (205)
Venture capital (34)
Weight loss (181)
Women's health (13)
Worklife (10)
Date
Today (34)
Last 7 days (105)
Last 30 days (343)
Last 365 days (5071)
2026 (528)
2025 (5124)
2024 (5600)
2023 (5864)
2022 (7522)
2021 (7920)
2020 (7578)
2019 (6116)
2018 (4586)
2017 (4282)
2016 (4279)
2015 (4947)
2014 (3519)
2013 (2574)
2012 (2836)
2011 (2893)
2010 (2351)
Location
Africa (181)
Alabama (9)
Alaska (3)
Arizona (26)
Asia (5131)
Australia (1086)
California (1515)
Canada (322)
China (172)
Colorado (80)
Connecticut (67)
Delaware (85)
Europe (13212)
Florida (221)
Georgia (47)
Hawaii (1)
Idaho (5)
Illinois (119)
India (14)
Indiana (108)
Japan (113)
Kansas (9)
Kentucky (2)
Louisiana (11)
Maine (46)
Maryland (207)
Massachusetts (1279)
Michigan (76)
Minnesota (105)
Missouri (7)
Montana (2)
Nebraska (5)
Nevada (12)
New Hampshire (15)
New Jersey (612)
New Mexico (11)
New York (634)
North Carolina (199)
Northern California (786)
Ohio (44)
Oklahoma (2)
Oregon (10)
Pennsylvania (346)
Puerto Rico (3)
Rhode Island (14)
South America (222)
South Carolina (3)
Southern California (551)
Tennessee (20)
Texas (278)
United States (6269)
Utah (49)
Virginia (39)
Washington D.C. (27)
Washington State (148)
Wisconsin (9)
Wyoming (1)
89,223 Results for "imidomics sl".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SELLAS Life Sciences Enters Agreement with IMPACT-AML to Expand SLS009 Clinical Program into Europe
January 15, 2026
·
5 min read
Press Releases
SL BIO Ltd. and Horizon Space Acquisition II Corp. Announce Registration Statement Effectiveness and Extraordinary General Meeting Date to Approve Business Combination
January 15, 2026
·
8 min read
Press Releases
Saol Therapeutics Has Been Granted a Type A Meeting with the FDA to Determine the Path Forward for SL1009 in Pyruvate Dehydrogenase Complex Deficiency (PDCD)
December 10, 2025
·
3 min read
Press Releases
SELLAS Life Sciences Presents Positive Phase 2 Data of SLS009 in Combination with AZA/VEN in Relapsed/Refractory AML-MR at ASH 2025
December 8, 2025
·
5 min read
Press Releases
Tonix Pharmaceuticals Announces FDA IND Clearance for Phase 2 Study of TNX-102 SL for the Treatment of Major Depressive Disorder
November 24, 2025
·
18 min read
Press Releases
ProImmune Ltd Introduces ProVE® SL Self‑Loading MHC Class I Monomers to Improve T Cell Research Flexibility
October 30, 2025
·
2 min read
Press Releases
Shattuck Labs Announces IND for SL-325 Is in Effect for the Treatment of Inflammatory Bowel Disease
August 22, 2025
·
5 min read
Press Releases
Tonix Pharmaceuticals Announces Positive Pre-IND Meeting with FDA for TNX-102 SL for the Treatment of Major Depressive Disorder
September 18, 2025
·
13 min read
Press Releases
Saol Therapeutics Receives Complete Response Letter from FDA for SL1009 (DCA) for the Treatment of Pyruvate Dehydrogenase Complex Deficiency (PDCD)
September 9, 2025
·
3 min read
Press Releases
SELLAS Life Sciences Announces Presentation of Phase 2 Data of SLS009 in Combination with Azacitidine and Venetoclax in Relapsed/Refractory AML with MDS-Related Changes (AML-MR) at the 2025 American Society of Hematology (ASH) Annual Meeting
November 4, 2025
·
4 min read
1 of 8,923
Next
